 |
|
|
| |
Absence of renal and bone toxicity in non-clinical studies of BMS-986001, a nucleoside reverse transcriptase inhibitor (NRTI) of human immunodeficiency virus (HIV)
|
| |
| |
Reported by Jules Levin
19th Intl AIDS Conference, July 22-27 2012 Washington DC
Mausumee Guha,1 Gary Pilcher,1 Jeffrey Moehlenkamp,1 Faye Wang,2 Shawn Clark,1 Frank Simutis,1 Oliver Flint,2 Roderick Bunch,1 Tom Sanderson,1 George J Hanna,3 Marc Davies3
1Bristol-Myers Squibb, Research and Development, Mt Vernon, IN, USA; 2Bristol-Myers Squibb, Research and Development, Lawrenceville, NJ, USA; 3Bristol-Myers Squibb, Research and Development, Princeton, NJ, USA
|
| |
|
|
|
|
|
